Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

Poster Session

Periodic Fever Syndromes, Autoinflammatory Diseases, Still’s Disease and MAS/HLH

Poster Session C

Session: (2015–2051) Miscellaneous Rheumatic & Inflammatory Diseases Poster III

2024: Racial Disparities in Outcomes Among Patients With Neuromyelitis Optica: A Global Population-Based Study

Tuesday, October 28, 2025
10:30 AM - 12:30 PM Central Time
Location: Hall F1
Table 1. Demographic Comparison of Blacks and Hispanics – Pre- and Post-Propensity Score Matching

Table 2. Clinical Outcomes

    Abstract Poster Presenter(s)

  • CO

    Chukwuemelie Okeke, MBBS

    Maimonides Medical Center
    Brooklyn, New York, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose


Background/Purpose: Neuromyelitis optica (NMO) is a rare, chronic, immune-mediated, demyelinating disorder predominantly affecting the optic nerve and spinal cord. Despite increasing awareness, racial disparities in NMO outcomes remain poorly characterized.

Methods: This retrospective cohort study used TriNetX, a global federated health research network of 144 healthcare organizations. Two Cohorts were defined: Cohort A (Black or African American with Neuromyelitis Optica; n= 2,101) and Cohort B ( Hispanics or Latinos with NMO; n= 1,007). Inclusion criteria required patients to be 18 years or older with at least an NMO diagnosis within the past 20 years. Exclusion criteria included patients younger than 18 or diagnosed more than 20 years ago.

Propensity score matching (1:1) was performed to balance demographics and comorbidities, including age, sex, obesity, dyslipidemia, diabetes, hypertension, kidney disease, and chronic respiratory disease. The final matched sample included 965 patients per group.

Outcomes assessed included all-cause mortality, stroke, and myocardial infarction (MI).

Results: After matching, both cohorts had similar characteristics (mean age 46 years; 76.7% female). Inflammatory markers such as ESR and CRP were higher in Black patients. All-cause mortality was significantly higher among Black patients compared to Hispanic patients (5.0% vs. 2.7%; OR 1.89, 95% CI 1.16–3.07). MI occurred in 4.4% of Black patients vs. 2.8% of Hispanic patients (OR 1.62, 95% CI 0.98–2.66). Stroke occurred in 3.2% of Black patients compared to 1.5% of Hispanic patients, with a statistically significant difference (OR 2.15, 95% CI 1.13–4.09).

Conclusion: This study’s findings underscore significant racial disparities in clinical outcomes among patients with Neuromyelitis Optica. Black patients had higher rates of all-cause mortality, myocardial infarction, and stroke compared to their Hispanic counterparts, despite comparable baseline characteristics. The elevated odds of death and cerebrovascular events in the Black cohort suggest potential underlying differences in disease progression, access to care, or treatment response. These results highlight the need for tailored interventions and equitable healthcare delivery to mitigate outcome disparities in NMO.